Yuce Biotechnology

Shenzhen, China Founded: 2015 • Age: 11 yrs
Gene detection services are developed for precise tumor immunotherapy.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Yuce Biotechnology

Yuce Biotechnology is a company based in Shenzhen (China) founded in 2015 by Gao Zhibo. Yuce Biotechnology operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.

  • Headquarter Shenzhen, China
  • Founders Gao Zhibo
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Huada Gene

    & 2 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Yuce Biotechnology

Investors in Yuce Biotechnology

Yuce Biotechnology has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Huada Gene, IDG Capital and Puhua Capital.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm
Locked Locked Locked
Health and technology startups are invested in by Puhua Capital.
Locked Locked Locked
Genomics research and sequencing services are provided in China.
Locked Locked Locked
Premium access

Investor details for Yuce Biotechnology

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Yuce Biotechnology

Investments
Premium access

Investment portfolio details for Yuce Biotechnology

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Yuce Biotechnology

Premium access

Detailed financials for Yuce Biotechnology

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Yuce Biotechnology Comparisons

Yuce Biotechnology Primary company
Description
Gene detection services are developed for precise tumor immu...
Location
Shenzhen, China
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Yuce Biotechnology

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Yuce Biotechnology

Yuce Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genomic database for clinical research is provided.
Locked Locked Locked
Cloud-based bioinformatics platform is offered for biotech research.
Locked Locked Locked
AI-based omics data analysis solutions are provided to researchers.
Locked Locked Locked
Developer of predictive informatics based platform for drug discovery
Locked Locked Locked
Bioinformatics platform is provided for biomarkers and drug discovery.
Locked Locked Locked
Genomic data is analyzed and interpreted via web-based applications.
Premium access

Detailed competitors of Yuce Biotechnology

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Yuce Biotechnology

Premium access

Complete news archive for Yuce Biotechnology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yuce Biotechnology

Yuce Biotechnology was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Yuce Biotechnology is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Gao Zhibo is the current CEO of Yuce Biotechnology. They have also founded this company.

Developer of gene detection services for precise immunotherapy of tumors. The company has developed an oncology drug using public data sources and mutation analysis modules. The flagship product, TrueNeon is artificial intelligence (AI) based tumor neoplastic antigen prediction technology based on tumor exon and transcriptome data. The company is using the TrueNeone platform for biomarker development, personalized cancer vaccines, and personalized cell therapy development. The company has also developed a tumor immunotherapy (IO) clinical trial navigation portal.

Yuce Biotechnology's top competitors include Helix, Benchling and BioAge Labs.

Yuce Biotechnology has 3 investors. Key investors include Huada Gene, IDG Capital, and Puhua Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available